Wolverine Asset Management LLC Tekla Life Sciences Investors Transaction History

Wolverine Asset Management LLC

$4.35 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$13.38 - $14.33 $2.58 Million - $2.76 Million	-192,463 Reduced 92.8%	14,929 $203,000
Q4 2023 Feb 01, 2024	SELL	$11.35 - $13.6 $1.3 Million - $1.56 Million	-114,766 Reduced 35.62%	207,392 $2.79 Million
Q3 2023 Nov 13, 2023	BUY	$12.38 - $13.69 $1.07 Million - $1.19 Million	86,671 Added 36.81%	322,158 $4.02 Million
Q2 2023 Aug 07, 2023	SELL	$13.13 - $14.17 $930,299 - $1 Million	-70,853 Reduced 23.13%	235,487 $3.19 Million
Q1 2023 May 08, 2023	BUY	$13.37 - $14.94 $478,672 - $534,881	35,802 Added 13.23%	306,340 $4.27 Million
Q4 2022 Feb 01, 2023	BUY	$13.55 - $15.23 $748,854 - $841,701	55,266 Added 25.67%	270,538 $3.84 Million
Q3 2022 Nov 10, 2022	BUY	$13.39 - $16.31 $831,398 - $1.01 Million	62,091 Added 40.53%	215,272 $2.94 Million
Q2 2022 Aug 03, 2022	BUY	$13.11 - $17.02 $1.69 Million - $2.19 Million	128,553 Added 521.98%	153,181 $2.18 Million
Q1 2022 May 04, 2022	BUY	$15.35 - $19.29 $378,039 - $475,074	24,628 New	24,628 $407,000
Q3 2020 Nov 13, 2020	SELL	$16.71 - $19.06 $43,228 - $49,308	-2,587 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$14.22 - $18.38 $4.31 Million - $5.57 Million	-302,987 Reduced 99.15%	2,587 $46,000
Q1 2020 May 13, 2020	SELL	$12.22 - $17.99 $390,734 - $575,230	-31,975 Reduced 9.47%	305,574 $4.58 Million
Q4 2019 Feb 14, 2020	BUY	$14.63 - $17.84 $1.74 Million - $2.12 Million	118,994 Added 54.45%	337,549 $5.88 Million
Q3 2019 Nov 14, 2019	BUY	$15.09 - $17.09 $664,367 - $752,421	44,027 Added 25.23%	218,555 $3.3 Million
Q2 2019 Aug 14, 2019	SELL	$15.54 - $17.47 $113,737 - $127,862	-7,319 Reduced 4.02%	174,528 $2.94 Million
Q1 2019 May 15, 2019	BUY	$15.5 - $17.9 $678,497 - $783,554	43,774 Added 31.7%	181,847 $3.12 Million
Q4 2018 Feb 14, 2019	BUY	$13.99 - $20.35 $1.93 Million - $2.81 Million	138,073 New	138,073 $2.09 Million
Q3 2018 Nov 14, 2018	SELL	$18.89 - $20.49 $1.14 Million - $1.24 Million	-60,362 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$18.13 - $19.4 $88,329 - $94,516	4,872 Added 8.78%	60,362 $1.13 Million
Q1 2018 May 15, 2018	BUY	$18.92 - $21.52 $1.05 Million - $1.19 Million	55,490 New	55,490 $1.07 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

9.31M

Call Options Held

Put Options Held

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$46.3 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.5 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.61 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.33 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.63 Million
0.14% of portfolio

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Account